National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 - specification under subsection 84AAA(2) (No. PB 56 of 2012)

Overview

The National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012, enacted to address the need for updating the list of pharmaceutical items under the Pharmaceutical Benefits Scheme (PBS) Safety Net, specifies the pharmaceutical benefits for which PBS Safety Net entitlements will not apply for early supplies. The amendment was made under subsection 84AAA(2) of the National Health Act 1953 and was introduced by the Minister for Health as a legislative instrument. The purpose of this legislative instrument is to insert new pharmaceutical items and delete an existing pharmaceutical item in the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009. The Pharmaceutical Benefits Advisory Committee recommended these changes, which are designed to ensure that decisions about access to medicines are evidence-based and aligned with the objective of achieving the highest attainable standard of physical and mental health. This legislative instrument is compatible with the human rights and freedoms recognised or declared in international instruments, particularly advancing the right to the highest attainable standard of physical and mental health by facilitating access to subsidised medicines.

Scope and Application

The National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 - specification under subsection 84AAA(2) is an amendment to the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 - specification under subsection 84AAA(2) (PB 30 of 2009). The amendment applies to the pharmaceutical items specified in the instrument that are pharmaceutical benefits for which Pharmaceutical Benefits Scheme (PBS) Safety Net entitlements will not apply for early supplies. The amendment is made under subsection 84AAA(2) of the National Health Act 1953, which provides that the Minister may specify, by legislative instrument, pharmaceutical items for the purposes of paragraph 84AAA(1)(b) of the Act. The amendment inserts new pharmaceutical items and deletes an existing pharmaceutical item. The amendment applies nationally and is made under the authority of the Commonwealth of Australia. The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that the pharmaceutical items referred to in this amendment be included in an instrument under subsection 84AAA(2). PBAC members are selected from consumers, health economists, practising community pharmacists, general practitioners, clinical pharmacologists and specialists, with at least one member selected from each of those interests or professions. The amendment is minor and machinery in nature. The National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 - specification under subsection 84AAA(2) is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. The PBS is a benefit scheme which assists with advancement of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. The recommendatory role of the PBAC ensures that decisions about subsidised access to medicines on the PBS are evidence-based. This legislative instrument engages Articles 2 and 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR) by assisting with the progressive realisation by all appropriate means of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. The amendment is compatible with human rights because it advances the protection of human rights.

Key Provisions

The National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 – specification under subsection 84AAA(2) modifies the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009). This amendment is focused on specifying pharmaceutical items that will not be subject to the Pharmaceutical Benefits Scheme (PBS) Safety Net entitlements for early supplies. The primary sections involved are subsections 84AAA(1) through 84AAA(3) of the National Health Act 1953, which outline the criteria for an early supply of a pharmaceutical benefit and the authority for specifying pharmaceutical items through a legislative instrument. Section 84AAA(2) allows the Minister to specify these items by legislative instrument, while section 84AAA(3) provides the flexibility to specify these items based on the circumstances of supply. The amendment specifies new pharmaceutical items to be added and an existing item to be deleted, ensuring that the list remains current and relevant. The Act imposes several obligations on parties involved in the pharmaceutical supply chain. Firstly, it requires pharmaceutical suppliers to adhere to the specified list of pharmaceutical items that are exempt from PBS Safety Net entitlements for early supplies. This means that if a supply of a specified pharmaceutical item meets the criteria of being an early supply, it will not be subject to the PBS Safety Net. Additionally, the Pharmaceutical Benefits Advisory Committee (PBAC) has a recommendatory role in advising the Minister on the pharmaceutical items to be specified, ensuring that the decisions are evidence-based and aligned with public health needs. Compliance with these obligations is crucial for maintaining the integrity of the PBS and ensuring that patients have appropriate access to necessary medications. Breaches of the provisions outlined in the Act may lead to civil or criminal consequences. Although the specific penalties are not detailed in the explanatory statement, it is implied that non-compliance with the legislative instrument could result in enforcement actions. The Minister has the authority to take action against parties that fail to adhere to the specified list of pharmaceutical items for early supplies. This could include penalties such as fines or other sanctions, depending on the nature and severity of the breach. It is essential for pharmaceutical suppliers and other relevant parties to understand and comply with the requirements to avoid any legal repercussions. In summary, the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 – specification under subsection 84AAA(2) serves to update the list of pharmaceutical items exempt from PBS Safety Net entitlements for early supplies. The Act outlines the criteria for early supply and the authority to specify these items, while also imposing obligations on parties to comply with the specified list. Non-compliance may result in civil or criminal penalties, emphasizing the importance of adhering to the legislative requirements.